Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| PAYS | Herman Joan M | EVP, Operations | 16.09.2026 | Verkauf | 11,74 | 38.900 | 456.830 | Form 4 |
| PAYS | Herman Joan M | EVP, Operations | 15.09.2026 | Verkauf | 12,38 | 21.004 | 260.069 | Form 4 |
| PAYS | Ngo Michael C | Chief Innovation Officer | 09.09.2026 | Verkauf | 12,74 | 79.925 | 1.018.245 | Form 4 |
| PAYS | Ngo Michael C | Chief Innovation Officer | 08.09.2026 | Verkauf | 12,85 | 70.075 | 900.422 | Form 4 |
| PAYS | Baker Jeffery Bradford | Chief Financial Officer | 12.08.2026 | Verkauf | 12,62 | 35.000 | 441.637 | Form 4 |
| PAYS | Newcomer Mark | CEO | 06.08.2026 | Verkauf | 11,88 | 150.000 | 1.781.355 | Form 4 |
| PAYS | Triplett Dennis L | Director | 04.08.2026 | Optionsausübung | — | 20.000 | — | Form 4 |
| PAYS | Newman Jeffrey B | Director | 04.08.2026 | Optionsausübung | — | 20.000 | — | Form 4 |
| PAYS | Mina Bruce A | Director | 04.08.2026 | Optionsausübung | — | 20.000 | — | Form 4 |
| PAYS | Henry Daniel R | Director | 04.08.2026 | Optionsausübung | — | 20.000 | — | Form 4 |
| PAYS | Cunningham Bradley Kramer | Chief Technology Officer | 31.07.2026 | Steuer-Abgabe | 8,96 | 22.430 | 200.973 | Form 4 |
| PAYS | Newcomer Mark | CEO | 31.07.2026 | Steuer-Abgabe | 8,96 | 59.025 | 528.864 | Form 4 |
| PAYS | Newcomer Mark | CEO | 31.07.2026 | Optionsausübung | — | 150.000 | — | Form 4 |
| PAYS | Lanford Matthew Louis | Chief Payments Officer | 31.07.2026 | Steuer-Abgabe | 8,96 | 25.185 | 225.658 | Form 4 |
| PAYS | Lanford Matthew Louis | Chief Payments Officer | 31.07.2026 | Optionsausübung | — | 64.000 | — | Form 4 |
| PAYS | Strobo Robert | Chief Legal Officer | 31.07.2026 | Steuer-Abgabe | 8,96 | 25.184 | 225.649 | Form 4 |
| PAYS | Strobo Robert | Chief Legal Officer | 31.07.2026 | Optionsausübung | — | 64.000 | — | Form 4 |
| PAYS | Herman Joan M | EVP, EFT Operations | 31.07.2026 | Steuer-Abgabe | 8,96 | 13.780 | 123.469 | Form 4 |
| PAYS | Herman Joan M | EVP, EFT Operations | 31.07.2026 | Optionsausübung | — | 36.000 | — | Form 4 |
| PAYS | Baker Jeffery Bradford | Chief Financial Officer | 31.07.2026 | Steuer-Abgabe | 8,96 | 28.506 | 255.414 | Form 4 |
| PAYS | Baker Jeffery Bradford | Chief Financial Officer | 31.07.2026 | Optionsausübung | — | 64.000 | — | Form 4 |
| PAYS | Newcomer Mark | CEO | 29.07.2026 | Verkauf | 9,38 | 50.000 | 468.985 | Form 4 |
| PAYS | Herman Joan M | EVP, Operations | 16.07.2026 | Verkauf | 8,69 | 28.000 | 243.410 | Form 4 |
| PAYS | Herman Joan M | EVP, Operations | 15.07.2026 | Verkauf | 8,60 | 31.904 | 274.253 | Form 4 |
| PAYS | Cunningham Bradley Kramer | Chief Technology Officer | 30.06.2026 | Steuer-Abgabe | 8,19 | 11.579 | 94.832 | Form 4 |
| PAYS | Mina Bruce A | Director | 11.06.2026 | Verkauf | 7,10 | 10.000 | 70.950 | Form 4 |
| PAYS | Cunningham Bradley Kramer | Chief Technology Officer | 01.06.2026 | Verkauf | 7,80 | 3.000 | 23.400 | Form 4 |
| PAYS | Mina Bruce A | Director | 01.06.2026 | Verkauf | 7,10 | 10.000 | 71.000 | Form 4 |
| PAYS | Cunningham Bradley Kramer | Chief Technology Officer | 29.05.2026 | Verkauf | 7,30 | 10.000 | 73.020 | Form 4 |
| PAYS | Turner Matthew Baker | PRES., PATIENT AFFORDABILITY | 22.05.2026 | Steuer-Abgabe | 6,72 | 50.681 | 340.576 | Form 4 |
| PAYS | Cunningham Bradley Kramer | Chief Technology Officer | 18.05.2026 | Steuer-Abgabe | 5,87 | 12.369 | 72.544 | Form 4 |
| PAYS | Triplett Dennis L | Director | 08.05.2026 | Zuteilung | — | 20.000 | — | Form 4 |
| PAYS | Newman Jeffrey B | Director | 08.05.2026 | Zuteilung | — | 20.000 | — | Form 4 |
| PAYS | Mina Bruce A | Director | 08.05.2026 | Zuteilung | — | 20.000 | — | Form 4 |
| PAYS | Henry Daniel R | Director | 08.05.2026 | Zuteilung | — | 20.000 | — | Form 4 |
| PAYS | Ngo Michael C | Chief Innovation Officer | 31.03.2026 | Steuer-Abgabe | 5,90 | 38.664 | 228.118 | Form 4 |
| PAYS | Turner Matthew Baker | PRES., PATIENT AFFORDABILITY | 03.02.2026 | Verkauf | 4,16 | 15.057 | 62.637 | Form 4 |
| PAYS | Turner Matthew Baker | PRES., PATIENT AFFORDABILITY | 13.11.2025 | Zuteilung | — | 233.333 | — | Form 4 |
| PAYS | Ngo Michael C | Chief Innovation Officer | 19.03.2025 | Zuteilung | — | 500.000 | — | Form 4 |
| PAYS | Ngo Michael C | Chief Innovation Officer | 19.03.2025 | Zuteilung | — | 2.500.000 | — | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).